Avalo Therapeutics grants options for 52,000 shares to three new employees
AVTX•Avalo Therapeutics granted nonstatutory stock options covering 52,000 shares to three new employees on Nov. 18, 2026.
1. Option grant
The options vest 25% on each employee’s first employment anniversary, with the remainder vesting monthly over 36 months. Vesting requires continued service under the terms of the 2025 Inducement Award Plan and related award agreements.




